China approves Merck antiviral as it battles COVID-19 wave
China's top drug regulator said Friday that it approved Merck & Co.'s Molnupiravir for emergency use on Thursday, as the country grapples with waves of infections after Beijing abruptly reversed its stringent Covid-19 restrictions earlier this month.
The National Medical Products Administration said it is requiring the approval holder to continue relevant research, complete conditional requirements and submit follow-up research results in a timely manner, according to a statement posted on its website Friday.This item was corrected at 0856 GMT to reflect China's top drug regulator said it approved Merck & Co.'s Molnupiravir for emergency use on Thursday.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China Approves Foreign Videogames in Latest Breather for Tech GiantsChina’s main videogame regulator approved 45 imported titles, including “Pokémon Unite” and “Game of Thrones: Winter is Coming”
Read more »
Snakeheads, Chinooks, Thrashers: U.S. approves $1.3 billion in Pa. military contractsDaily News | Snakeheads, Chinooks, Thrashers: U.S. approves $1.3 billion in Pa. military contracts
Read more »
US bankruptcy court approves $121M clergy abuse settlementA federal bankruptcy judge has approved a $121 million reorganization plan for one of the oldest Roman Catholic dioceses in the U.S. as it tries to stem financial losses from clergy abuse claims that date back decades
Read more »
Dubai approves extradition of financier accused of tax fraudDUBAI, United Arab Emirates (AP) — A court in Dubai on Thursday approved the extradition to Denmark of a British financier accused of orchestrating a $1.7 billion tax scheme. Hedge fund trader Sanjay Shah is accused of masterminding a scheme that ran from 2012 to 2015 in which foreign businesses pretended to own shares in Danish companies and claimed tax refunds for which they were not eligible.
Read more »
U.S. FDA approves TG Therapeutics' multiple sclerosis drugTG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up nearly 9% in afternoon trade.
Read more »